Stockreport

enGene Holdings: A Potential Oncology Entrant [Seeking Alpha]

enGene Holdings Inc.  (ENGN) 
PDF ENGN's DDX gene delivery platform enables localized, multi-gene non-viral therapies, aiming to overcome immunogenicity and toxicity challenges. Despite promising data [Read more]